Log in

ResultsMint

Five pharma CDMO stocks with robust revenue growth in Q2FY27

Positive+32

GreyOak summary

Global pharmaceutical companies are outsourcing research and manufacturing to diversify supply chains and lower costs.

What it affects

  • HealthcarePositive +32

    Rolling sentiment Positive +34

Source

Reported by Mint

More news

All news →

Indices and sectors in this story

Latest market news

News Intelligence →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy